Devices will allow upgrade from legacy film-based radiotherapy systems.
PerkinElmer entered into a joint technology development and marketing agreement with LinaTech. The companies will develop, implement, market and distribute imaging technologies for the treatment of various cancers.
The proposed products will include cost-effective imaging solutions that allow customers to upgrade their legacy film-based radiotherapy systems. They will also incorporate imaging subsystems for sales to radiotherapy system manufacturers.
“We look forward to very compelling outcomes from our development project, as we seek to create new technologies for the benefit of cancer patients by giving doctors and hospitals more imaging options,” says Brian Giambattista, president, medical imaging, PerkinElmer.
A first-generation imaging product, the FDA 510k-approved LinaTech TiGRT Image Viewing System, will be showcased at the American Society of Therapeutic Radiology and Oncology in San Diego. It is a Patient Position Verification and Electronic Portal Imaging Device system and is used for patient position verification, patient tumor tracking and localization, portal verification and record, dynamic MLC leaf detection, dosimetry verification, and exist dose recording.